Rating History for Inhibikase Therapeutics Inc (IKT) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/4/2026 | Aydin Huseynov | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.91 (2.11) |
10.47% | Details |
